Atlas Trials

GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Glucose Monitoring (CGM) by Using FreeStyle Libre 2 (FSL2) for Preventing Hyperglycemia/Hypoglycemia Crisis in Advanced Oncological Patients.

Clinical trial NCT04942756 · UNKNOWN

Trial details

NCT number
NCT04942756
Sponsor
Antea Foundation
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Palliative CareDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1DiabetesCancerTerminal CancerTerminal IllnessEnd Stage CancerAdvanced Cancer
Start date
2021-06-30
Primary completion
2022-06-30
Enrollment
118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.